Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 51.38% institutional investors, 25.65% insiders, and 22.98% retail investors. Fmr is the largest institutional shareholder, holding 8.93% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.83% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Roivant Sciences | 51.38% | 25.65% | 22.98% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 60.77M | 8.93% | $919.40M |
| Morgan stanley | 44.32M | 6.52% | $670.60M |
| Sb investment advisers (uk) | 40.32M | 5.93% | $609.97M |
| Blackrock funding, inc. /de | 39.72M | 5.84% | $601.04M |
| Vanguard group | 38.80M | 5.70% | $587.12M |
| Blackrock | 35.37M | 4.41% | $373.86M |
| Qvt financial lp | 29.38M | 4.32% | $444.54M |
| Viking global investors lp | 23.59M | 3.47% | $356.99M |
| Rubric capital management lp | 20.00M | 2.94% | $302.60M |
| State street | 18.70M | 2.75% | $282.93M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Patient square capital lp | 12.48M | 50.51% | $188.82M |
| Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
| Qvt financial lp | 29.38M | 31.37% | $444.54M |
| Whitefort capital management, lp | 3.53M | 15.79% | $53.44M |
| Stempoint capital lp | 4.20M | 12.72% | $63.50M |
| Cutter capital management, lp | 1.30M | 5.71% | $13.12M |
| Blackbarn capital partners lp | 4.40M | 4.76% | $66.57M |
| Adar1 capital management | 3.35M | 4.76% | $50.65M |
| Prosight management, lp | 1.34M | 4.71% | $20.21M |
| Blue owl capital lp | 988.25K | 4.64% | $14.95M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 60.77M | 0.05% | 5.26M |
| Adage capital partners gp | 7.23M | 0.17% | 5.15M |
| Norges bank | 4.43M | 0.01% | 4.43M |
| Perceptive advisors | 7.37M | 3.22% | 4.04M |
| Stempoint capital lp | 4.20M | 12.72% | 3.60M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sb investment advisers (uk) | 40.32M | 4.60% | -19.64M |
| Viking global investors lp | 23.59M | 0.93% | -10.64M |
| Anchorage capital group | - | - | -4.83M |
| Avoro capital advisors | - | - | -4.65M |
| Toms capital investment management lp | - | - | -4.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 4.43M | 0.01% | 4.43M | $52.44M |
| Voloridge investment management | 2.28M | 0.12% | 2.28M | $34.51M |
| Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
| Balyasny asset management | 969.98K | 0.02% | 969.98K | $10.93M |
| First turn management | 959.70K | 2.18% | 959.70K | $14.52M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -2.00 |
| Stephens consulting | -3.00 |
| Northwestern mutual wealth management | -10.00 |
| Mather group, llc. | -13.00 |
| Cornerstone planning group | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 297 | -14.41% | 349,519,827 | -24.94% | 51 | 1.19% | 157 | -11.80% | 81 | -23.58% |
| Jun 30, 2025 | 351 | 8.67% | 514,292,667 | -7.04% | 72 | 1.24% | 180 | 19.21% | 107 | 0.94% |
| Mar 31, 2025 | 15 | -95.41% | 102,194,746 | -81.83% | 14 | 0.23% | 6 | -96.18% | 3 | -97.12% |
| Dec 31, 2024 | 293 | -4.87% | 455,984,070 | -19.26% | 61 | 1.05% | 142 | -20.22% | 95 | 35.71% |
| Sep 30, 2024 | 306 | 0.66% | 564,022,060 | 3.35% | 76 | 1.39% | 177 | 4.12% | 69 | -14.81% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 26.16M | 3.83% | 990.65K |
| Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
| Fidelity Growth Company Fund | 19.18M | 2.81% | 557.44K |
| iShares Core S&P Mid-Cap ETF | 13.70M | 2.01% | - |
| Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
| Vanguard Total Stock Mkt Idx Inv | 13.12M | 1.92% | -274.00K |
| Vanguard Small Cap Index | 9.90M | 1.45% | -71.12K |
| SPDR® S&P Biotech ETF | 7.21M | 1.06% | 16.07K |
| Invesco S&P MidCap Quality ETF | 6.02M | 0.89% | - |
| Fidelity Growth Company K6 | 5.68M | 0.83% | 272.81K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 09, 2025 | Venker Eric | President & Immunovant CEO | Sell | $4.17M |
| Nov 19, 2025 | MANCHESTER KEITH S | - | Sell | $3.54M |
| Nov 19, 2025 | MANCHESTER KEITH S | - | Sell | $17.21M |
| Nov 19, 2025 | MANCHESTER KEITH S | - | Sell | $3.03M |
| Nov 19, 2025 | MANCHESTER KEITH S | - | Sell | $2.52M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 25 |
| 2025 Q3 | 1 | 9 |
| 2025 Q2 | - | 11 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | 8 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools